Security Snapshot

Proto Labs Inc - Common Stock (PRLB) Institutional Ownership

CUSIP: 743713109

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

233

Shares (Excl. Options)

21,768,574

Price

$50.59

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
PRLB on NYSE
Shares outstanding
23,799,118
Price per share
$57.02
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
21,768,574
Total reported value
$1,101,482,436
% of total 13F portfolios
0%
Share change
+26,486
Value change
+$1,524,141
Number of holders
233
Price from insider filings
$57.02
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • PRLB - Proto Labs Inc - Common Stock is tracked under CUSIP 743713109.
  • 233 institutions reported positions in Q4 2025.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 233 to 56 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,101,482,436 to $57,015,296.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 233 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 743713109?
CUSIP 743713109 identifies PRLB - Proto Labs Inc - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Proto Labs Inc - Common Stock (PRLB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $142,296,875 3,553,868 BlackRock, Inc. 30 Jun 2025
DISCIPLINED GROWTH INVESTORS INC /MN 11% +3.6% $146,867,934 +$4,468,885 2,673,729 +3.1% DISCIPLINED GROWTH INVESTORS INC /MN 31 Dec 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 6.5% $88,300,887 1,548,595 Vanguard Portfolio Management 31 Mar 2026
DIMENSIONAL FUND ADVISORS LP 5.3% $46,037,577 1,300,864 Dimensional Fund Advisors LP 31 Dec 2024
VANGUARD CAPITAL MANAGEMENT LLC 5.1% $69,208,310 1,213,755 Vanguard Capital Management 31 Mar 2026

As of 31 Dec 2025, 233 institutional investors reported holding 21,768,574 shares of Proto Labs Inc - Common Stock (PRLB). This represents 91% of the company’s total 23,799,118 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Proto Labs Inc - Common Stock (PRLB) together control 76% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 3,619,004 -0.07% 0% $183,085,413
DISCIPLINED GROWTH INVESTORS INC /MN 11% 2,673,729 +3.1% 2.6% $135,263,950
VANGUARD GROUP INC 11% 2,666,227 -2.9% 0% $134,884,424
DIMENSIONAL FUND ADVISORS LP 5.4% 1,276,561 -2.3% 0.01% $64,583,030
Rubric Capital Management LP 4.7% 1,123,338 0% 0.68% $56,829,669
STATE STREET CORP 4.6% 1,088,206 -7.4% 0% $55,052,342
AMERICAN CAPITAL MANAGEMENT INC 2.7% 631,311 +126% 1.4% $31,938,023
GEODE CAPITAL MANAGEMENT, LLC 2.3% 558,300 -1.5% 0% $28,249,952
RENAISSANCE TECHNOLOGIES LLC 2.1% 493,551 -9.2% 0.04% $24,968,745
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.9% 460,618 0% 0.01% $23,302,665
Driehaus Capital Management LLC 1.6% 382,155 0.13% $19,333,221
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.5% 363,013 +9.5% 0% $18,364,828
Nuveen, LLC 1.4% 325,750 -1.3% 0% $16,479,692
S Squared Technology, LLC 1.3% 306,103 -1.6% 6% $15,485,751
MORGAN STANLEY 1.3% 305,612 -0.13% 0% $15,461,002
NORTHERN TRUST CORP 1.1% 256,268 -8.1% 0% $12,964,598
NORDEA INVESTMENT MANAGEMENT AB 0.94% 224,439 -13% 0.01% $11,504,744
D. E. Shaw & Co., Inc. 0.89% 212,868 -40% 0.01% $10,768,992
JUPITER ASSET MANAGEMENT LTD 0.82% 194,832 0% 0.08% $9,856,551
PRUDENTIAL FINANCIAL INC 0.77% 182,826 +136% 0.01% $9,249,167
PANAGORA ASSET MANAGEMENT INC 0.74% 175,585 +4.3% 0.03% $8,882,845
UBS Group AG 0.74% 175,416 -0.83% 0% $8,874,296
Hillsdale Investment Management Inc. 0.71% 168,284 -0.77% 0.23% $8,513,487
GOLDMAN SACHS GROUP INC 0.67% 160,604 +11% 0% $8,124,956
Bank of New York Mellon Corp 0.6% 142,995 -3.4% 0% $7,234,102

Institutional Holders of Proto Labs Inc - Common Stock (PRLB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,000,086 $57,015,296 -$3,794,545 $57.02 56
2025 Q4 21,768,574 $1,101,482,436 +$1,524,141 $50.59 233
2025 Q3 21,734,265 $1,087,223,760 +$7,578,886 $50.03 211
2025 Q2 21,644,811 $866,661,340 -$3,320,676 $40.04 199
2025 Q1 21,833,014 $764,932,838 +$12,721,358 $35.04 188
2024 Q4 21,413,334 $837,171,404 -$1,936,132 $39.09 198
2024 Q3 21,601,786 $634,296,323 +$12,457,335 $29.37 193
2024 Q2 21,463,987 $662,934,572 -$6,290,130 $30.89 205
2024 Q1 21,664,592 $774,219,900 -$2,861,632 $35.75 203
2023 Q4 21,716,420 $845,829,890 +$100,687 $38.96 218
2023 Q3 21,644,485 $571,391,110 -$27,189,078 $26.40 183
2023 Q2 22,185,087 $775,566,005 -$12,018,822 $34.96 190
2023 Q1 22,494,016 $745,535,696 -$15,435,457 $33.15 195
2022 Q4 23,287,357 $594,563,505 -$42,744,310 $25.53 193
2022 Q3 24,260,677 $881,194,677 -$8,850,441 $36.43 189
2022 Q2 24,466,497 $1,162,030,563 -$6,352,462 $47.84 207
2022 Q1 24,694,338 $1,306,191,660 -$36,560,161 $52.90 217
2021 Q4 25,371,389 $1,303,565,237 -$166,847,087 $51.35 222
2021 Q3 28,263,246 $1,882,987,161 -$47,769,900 $66.60 248
2021 Q2 28,727,914 $2,635,481,077 -$14,885,666 $91.80 260
2021 Q1 28,551,256 $3,475,713,832 -$300,436,753 $121.75 303
2020 Q4 30,946,840 $4,747,961,335 +$157,898,016 $153.40 296
2020 Q3 30,073,363 $3,893,761,408 +$1,972,542 $129.50 274
2020 Q2 30,050,881 $3,370,920,361 +$27,692,547 $112.47 274
2020 Q1 29,855,726 $2,273,297,211 +$94,366,862 $76.13 220
2019 Q4 27,824,637 $2,827,089,990 +$82,362,910 $101.55 242
2019 Q3 26,981,624 $2,754,490,160 +$134,554,432 $102.10 239
2019 Q2 25,635,872 $2,973,483,855 +$108,513,179 $116.02 235
2019 Q1 24,818,603 $2,609,641,497 -$6,118,180 $105.14 255
2018 Q4 25,168,810 $2,839,412,863 -$99,002,937 $112.79 263
2018 Q3 25,876,599 $4,185,474,591 +$11,651,701 $161.75 257
2018 Q2 25,900,338 $3,081,527,028 +$5,940,465 $118.95 243
2018 Q1 25,872,628 $3,041,485,874 -$68,758,795 $117.55 245
2017 Q4 26,408,585 $2,720,368,450 -$108,580,814 $103.00 226
2017 Q3 27,644,326 $2,218,891,994 +$5,157,496 $80.30 200
2017 Q2 27,753,747 $1,866,478,820 +$114,948,103 $67.25 189
2017 Q1 27,342,585 $1,397,916,435 +$91,569,737 $51.10 181
2016 Q4 28,381,030 $1,457,809,365 -$32,334,381 $51.35 192
2016 Q3 28,297,566 $1,694,022,649 -$27,564,261 $59.91 200
2016 Q2 28,627,566 $1,647,755,272 +$5,959,749 $57.56 214
2016 Q1 29,003,063 $2,235,651,297 +$141,799,580 $77.09 207
2015 Q4 27,433,950 $1,747,374,582 -$24,625,300 $63.69 195
2015 Q3 27,094,354 $1,815,289,335 +$193,116,986 $67.00 191
2015 Q2 24,459,076 $1,650,457,144 -$80,190,159 $67.48 177
2015 Q1 25,433,237 $1,780,345,890 -$11,741,146 $70.00 177
2014 Q4 25,843,887 $1,735,517,310 +$84,276,123 $67.16 174
2014 Q3 24,665,594 $1,701,556,736 -$15,352,364 $69.00 183
2014 Q2 24,773,472 $2,029,428,390 +$114,585,015 $81.92 177
2014 Q1 23,464,686 $1,587,178,268 +$51,584,375 $67.67 175
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .